Australia markets open in 9 hours 15 minutes

Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
21.15+0.06 (+0.28%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.95B
Enterprise value 5.12B
Trailing P/E 12.94
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.73
Price/book (mrq)1.60
Enterprise value/revenue 1.84
Enterprise value/EBITDA 8.09

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3-26.34%
S&P500 52-week change 322.64%
52-week high 329.33
52-week low 315.57
50-day moving average 319.68
200-day moving average 322.70

Share statistics

Avg vol (3-month) 31.33M
Avg vol (10-day) 32.01M
Shares outstanding 5234.61M
Implied shares outstanding 6237.01M
Float 8111.54M
% held by insiders 155.26%
% held by institutions 12.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 43.00%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 32.84%
5-year average dividend yield 4N/A
Payout ratio 440.27%
Dividend date 3N/A
Ex-dividend date 428 Apr 2023
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 12.79%
Operating margin (ttm)16.25%

Management effectiveness

Return on assets (ttm)5.72%
Return on equity (ttm)12.60%

Income statement

Revenue (ttm)2.65B
Revenue per share (ttm)11.65
Quarterly revenue growth (yoy)5.50%
Gross profit (ttm)N/A
EBITDA 505.96M
Net income avi to common (ttm)339.41M
Diluted EPS (ttm)1.55
Quarterly earnings growth (yoy)-20.50%

Balance sheet

Total cash (mrq)909.16M
Total cash per share (mrq)3.98
Total debt (mrq)1.23B
Total debt/equity (mrq)43.98%
Current ratio (mrq)2.55
Book value per share (mrq)12.23

Cash flow statement

Operating cash flow (ttm)660.89M
Levered free cash flow (ttm)-537.06M